Prospective, randomized, single-blind comparison of effects of 6 months' treatment with atorvastatin versus pravastatin on leptin and angiogenic factors in patients with coronary artery disease

Leptin has been reported to exert an atherosclerotic effect by regulating expression of angiogenic factors that have been implicated in the pathogenesis of coronary artery disease (CAD). The purpose of this study was to investigate whether lipid-lowering therapy (LLT) with statins could affect lepti...

Full description

Saved in:
Bibliographic Details
Published inHeart and vessels Vol. 27; no. 4; pp. 337 - 343
Main Authors Takahashi, Yuji, Satoh, Mamoru, Tabuchi, Tsuyoshi, Nakamura, Motoyuki
Format Journal Article
LanguageEnglish
Published Japan Springer Japan 01.07.2012
Springer Nature B.V
Subjects
Online AccessGet full text
ISSN0910-8327
1615-2573
1615-2573
DOI10.1007/s00380-011-0156-y

Cover

Abstract Leptin has been reported to exert an atherosclerotic effect by regulating expression of angiogenic factors that have been implicated in the pathogenesis of coronary artery disease (CAD). The purpose of this study was to investigate whether lipid-lowering therapy (LLT) with statins could affect leptin levels and angiogenic factors in patients with CAD. This study included 76 patients with CAD and 15 subjects without CAD (non-CAD). CAD patients were randomized to 6 months of intensive LLT with atorvastatin or moderate LLT with pravastatin. Plasma leptin, angiopoetin-2 (Ang-2), hepatocyte growth factor (HGF) and vascular endothelial growth factor (VEGF) levels were measured prior to statin therapy (baseline) and after 6 months. Baseline levels of leptin, Ang-2, HGF and VEGF were higher in the CAD group than in the non-CAD group (all P  < 0.05). Treatment with intensive LLT decreased leptin, Ang-2, HGF and VEGF levels, whereas moderate LLT did not change these levels. This study suggests that LLT with atorvastatin decreases leptin levels and angiogenic factors in patients with CAD, possibly contributing to the beneficial effects of LLT with atorvastatin in CAD.
AbstractList Leptin has been reported to exert an atherosclerotic effect by regulating expression of angiogenic factors that have been implicated in the pathogenesis of coronary artery disease (CAD). The purpose of this study was to investigate whether lipid-lowering therapy (LLT) with statins could affect leptin levels and angiogenic factors in patients with CAD. This study included 76 patients with CAD and 15 subjects without CAD (non-CAD). CAD patients were randomized to 6 months of intensive LLT with atorvastatin or moderate LLT with pravastatin. Plasma leptin, angiopoetin-2 (Ang-2), hepatocyte growth factor (HGF) and vascular endothelial growth factor (VEGF) levels were measured prior to statin therapy (baseline) and after 6 months. Baseline levels of leptin, Ang-2, HGF and VEGF were higher in the CAD group than in the non-CAD group (all P < 0.05). Treatment with intensive LLT decreased leptin, Ang-2, HGF and VEGF levels, whereas moderate LLT did not change these levels. This study suggests that LLT with atorvastatin decreases leptin levels and angiogenic factors in patients with CAD, possibly contributing to the beneficial effects of LLT with atorvastatin in CAD.
Leptin has been reported to exert an atherosclerotic effect by regulating expression of angiogenic factors that have been implicated in the pathogenesis of coronary artery disease (CAD). The purpose of this study was to investigate whether lipid-lowering therapy (LLT) with statins could affect leptin levels and angiogenic factors in patients with CAD. This study included 76 patients with CAD and 15 subjects without CAD (non-CAD). CAD patients were randomized to 6 months of intensive LLT with atorvastatin or moderate LLT with pravastatin. Plasma leptin, angiopoetin-2 (Ang-2), hepatocyte growth factor (HGF) and vascular endothelial growth factor (VEGF) levels were measured prior to statin therapy (baseline) and after 6 months. Baseline levels of leptin, Ang-2, HGF and VEGF were higher in the CAD group than in the non-CAD group (all P < 0.05). Treatment with intensive LLT decreased leptin, Ang-2, HGF and VEGF levels, whereas moderate LLT did not change these levels. This study suggests that LLT with atorvastatin decreases leptin levels and angiogenic factors in patients with CAD, possibly contributing to the beneficial effects of LLT with atorvastatin in CAD.[PUBLICATION ABSTRACT]
Leptin has been reported to exert an atherosclerotic effect by regulating expression of angiogenic factors that have been implicated in the pathogenesis of coronary artery disease (CAD). The purpose of this study was to investigate whether lipid-lowering therapy (LLT) with statins could affect leptin levels and angiogenic factors in patients with CAD. This study included 76 patients with CAD and 15 subjects without CAD (non-CAD). CAD patients were randomized to 6 months of intensive LLT with atorvastatin or moderate LLT with pravastatin. Plasma leptin, angiopoetin-2 (Ang-2), hepatocyte growth factor (HGF) and vascular endothelial growth factor (VEGF) levels were measured prior to statin therapy (baseline) and after 6 months. Baseline levels of leptin, Ang-2, HGF and VEGF were higher in the CAD group than in the non-CAD group (all P < 0.05). Treatment with intensive LLT decreased leptin, Ang-2, HGF and VEGF levels, whereas moderate LLT did not change these levels. This study suggests that LLT with atorvastatin decreases leptin levels and angiogenic factors in patients with CAD, possibly contributing to the beneficial effects of LLT with atorvastatin in CAD.Leptin has been reported to exert an atherosclerotic effect by regulating expression of angiogenic factors that have been implicated in the pathogenesis of coronary artery disease (CAD). The purpose of this study was to investigate whether lipid-lowering therapy (LLT) with statins could affect leptin levels and angiogenic factors in patients with CAD. This study included 76 patients with CAD and 15 subjects without CAD (non-CAD). CAD patients were randomized to 6 months of intensive LLT with atorvastatin or moderate LLT with pravastatin. Plasma leptin, angiopoetin-2 (Ang-2), hepatocyte growth factor (HGF) and vascular endothelial growth factor (VEGF) levels were measured prior to statin therapy (baseline) and after 6 months. Baseline levels of leptin, Ang-2, HGF and VEGF were higher in the CAD group than in the non-CAD group (all P < 0.05). Treatment with intensive LLT decreased leptin, Ang-2, HGF and VEGF levels, whereas moderate LLT did not change these levels. This study suggests that LLT with atorvastatin decreases leptin levels and angiogenic factors in patients with CAD, possibly contributing to the beneficial effects of LLT with atorvastatin in CAD.
Leptin has been reported to exert an atherosclerotic effect by regulating expression of angiogenic factors that have been implicated in the pathogenesis of coronary artery disease (CAD). The purpose of this study was to investigate whether lipid-lowering therapy (LLT) with statins could affect leptin levels and angiogenic factors in patients with CAD. This study included 76 patients with CAD and 15 subjects without CAD (non-CAD). CAD patients were randomized to 6 months of intensive LLT with atorvastatin or moderate LLT with pravastatin. Plasma leptin, angiopoetin-2 (Ang-2), hepatocyte growth factor (HGF) and vascular endothelial growth factor (VEGF) levels were measured prior to statin therapy (baseline) and after 6 months. Baseline levels of leptin, Ang-2, HGF and VEGF were higher in the CAD group than in the non-CAD group (all P  < 0.05). Treatment with intensive LLT decreased leptin, Ang-2, HGF and VEGF levels, whereas moderate LLT did not change these levels. This study suggests that LLT with atorvastatin decreases leptin levels and angiogenic factors in patients with CAD, possibly contributing to the beneficial effects of LLT with atorvastatin in CAD.
Author Tabuchi, Tsuyoshi
Nakamura, Motoyuki
Takahashi, Yuji
Satoh, Mamoru
Author_xml – sequence: 1
  givenname: Yuji
  surname: Takahashi
  fullname: Takahashi, Yuji
  organization: Department of Internal Medicine, Division of Cardiology and Memorial Heart Center, Iwate Medical University School of Medicine
– sequence: 2
  givenname: Mamoru
  surname: Satoh
  fullname: Satoh, Mamoru
  email: m_satoh@imu.ncvc.go.jp
  organization: Department of Internal Medicine, Division of Cardiology and Memorial Heart Center, Iwate Medical University School of Medicine
– sequence: 3
  givenname: Tsuyoshi
  surname: Tabuchi
  fullname: Tabuchi, Tsuyoshi
  organization: Department of Internal Medicine, Division of Cardiology and Memorial Heart Center, Iwate Medical University School of Medicine
– sequence: 4
  givenname: Motoyuki
  surname: Nakamura
  fullname: Nakamura, Motoyuki
  organization: Department of Internal Medicine, Division of Cardiology and Memorial Heart Center, Iwate Medical University School of Medicine
BackLink https://www.ncbi.nlm.nih.gov/pubmed/21643812$$D View this record in MEDLINE/PubMed
BookMark eNp9ks1uFDEMxyNURD_gAbigSBzg0IF8zGZmjlXFl1QJDnAeZRLPNtVMMsTZRcvT8Cx9MrzaUqFKcLBsJb-_7cQ-ZUcxRWDsuRRvpBDNWxRCt6ISUpKtTLV7xE6kkatKrRp9xE5EJ0XVatUcs1PEG0FQJ7sn7FhJU-tWqhN2-yUnXMCVsIVznm30aQ4_wZ9zDHE9QTVMIXru0rzYHDBFnkYO40gK3Ifm9tecYrnGV7xksGWGWPiPUK65LSlvLRZbQuRbyLhBvmR7f0SpJlj2ERUlW4e0hhgcH60jKXK6WYikhHjI6FJO0eYdt7kAOR8QLMJT9ni0E8KzO3_Gvr1_9_XyY3X1-cOny4uryunOlMq3nZFeNt6KVnrndT2KzmovBgfSKTCDb32tpDJ2rH1Td0Z3YpANDAraulb6jL0-5F1y-r4BLP0c0ME02Qhpg70Uqu60aURL6MsH6E3a5Ejd9bI2SneyFoaoF3fUZpjB90sOMz2v_zMdAuQBcDQkzDDeI1L0-w3oDxvQ0wb0-w3od6RpHmhc2H84DSnbMP1XqQ5KpCpxDfmvpv8p-g38YMrG
CODEN HEVEEO
CitedBy_id crossref_primary_10_1038_s41598_020_74326_z
crossref_primary_10_1016_j_biochi_2023_04_011
crossref_primary_10_3390_vaccines4030026
crossref_primary_10_1016_j_orcp_2013_04_001
crossref_primary_10_1016_j_clnu_2014_12_017
crossref_primary_10_1002_mds_26678
crossref_primary_10_14814_phy2_13566
crossref_primary_10_1007_s10552_014_0488_x
crossref_primary_10_1016_j_jns_2014_11_029
crossref_primary_10_3390_biomedicines9111657
crossref_primary_10_1007_s00392_016_0996_7
crossref_primary_10_32415_jscientia_2023_9_6_6_17
crossref_primary_10_1016_j_cbi_2017_06_026
crossref_primary_10_3760_cma_j_issn_0366_6999_20140640
crossref_primary_10_3109_00365513_2015_1033742
crossref_primary_10_1038_s41598_022_16053_1
crossref_primary_10_1186_s13023_019_1211_5
crossref_primary_10_1007_s00380_012_0243_8
crossref_primary_10_1007_s00380_014_0473_z
crossref_primary_10_1007_s00380_015_0686_9
crossref_primary_10_1002_art_39010
crossref_primary_10_1038_aps_2018_40
crossref_primary_10_3390_ijms22094633
crossref_primary_10_1016_j_bcp_2013_09_004
crossref_primary_10_1007_s10557_012_6412_2
crossref_primary_10_1016_j_jns_2014_11_030
crossref_primary_10_3892_etm_2014_2027
Cites_doi 10.1172/JCI32239
10.1038/ijo.2008.224
10.1038/nri1350
10.1161/01.CIR.0000138112.90641.7F
10.1016/j.plipres.2004.03.001
10.1016/j.cccn.2005.04.021
10.1038/381745a0
10.1371/journal.pone.0002535
10.1126/science.281.5383.1683
10.1056/NEJMoa040583
10.1111/j.1464-5491.2006.01849.x
10.1007/s00380-010-0016-1
10.1046/j.1365-2796.1999.00571.x
10.1016/S0140-6736(05)76154-7
10.2337/diacare.28.3.754
10.1080/08037050410021405
10.1007/s00380-008-1038-9
10.1161/hc5001.101061
10.1161/01.CIR.0000033219.24717.52
10.1073/pnas.101564798
10.1016/j.atherosclerosis.2006.03.003
10.1001/jama.291.9.1071
10.1161/01.CIR.0000127960.28627.75
10.1016/j.amjcard.2005.07.013
10.1016/j.atherosclerosis.2007.01.040
10.1038/emm.2001.17
10.1093/clinchem/18.6.499
10.1161/01.CIR.0000131517.20177.5a
10.1096/fasebj.13.10.1231
ContentType Journal Article
Copyright Springer 2011
Springer 2012
Copyright_xml – notice: Springer 2011
– notice: Springer 2012
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7QO
7RV
7X7
7XB
88E
8AO
8FD
8FI
8FJ
8FK
8G5
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
GUQSH
K9.
M0S
M1P
M2O
MBDVC
NAPCQ
P64
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
Q9U
7X8
DOI 10.1007/s00380-011-0156-y
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Biotechnology Research Abstracts
ProQuest Central Nursing & Allied Health database (via ProQuest)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Technology Research Database
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
Research Library
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
Research Library Prep
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni Edition)
Medical Database
Research Library
Research Library (Corporate)
Nursing & Allied Health Premium
Biotechnology and BioEngineering Abstracts
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Research Library Prep
ProQuest Central Student
Technology Research Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
Research Library (Alumni Edition)
ProQuest Pharma Collection
ProQuest Central China
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Biotechnology Research Abstracts
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
ProQuest Research Library
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Central Basic
ProQuest One Academic Eastern Edition
ProQuest Nursing & Allied Health Source
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
Engineering Research Database
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE
Research Library Prep
MEDLINE - Academic

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: http://www.proquest.com/pqcentral?accountid=15518
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Anatomy & Physiology
EISSN 1615-2573
EndPage 343
ExternalDocumentID 3140717761
21643812
10_1007_s00380_011_0156_y
Genre Comparative Study
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations Japan
GeographicLocations_xml – name: Japan
GroupedDBID ---
-53
-5E
-5G
-BR
-EM
-Y2
-~C
.86
.GJ
.VR
06C
06D
0R~
0VY
1N0
1SB
203
28-
29I
29~
2J2
2JN
2JY
2KG
2LR
2P1
2VQ
2~H
30V
36B
3O-
3V.
4.4
406
408
409
40D
40E
53G
5GY
5QI
5RE
5VS
67Z
6NX
7X7
88E
8AO
8FI
8FJ
8G5
8TC
8UJ
95-
95.
95~
96X
AAAVM
AABHQ
AACDK
AAHNG
AAIAL
AAJBT
AAJKR
AANXM
AANZL
AARHV
AARTL
AASML
AATNV
AATVU
AAUYE
AAWCG
AAYIU
AAYQN
AAYTO
AAYZH
ABAKF
ABBBX
ABBXA
ABDZT
ABECU
ABFTV
ABHLI
ABHQN
ABIPD
ABJNI
ABJOX
ABKCH
ABKTR
ABMNI
ABMQK
ABNWP
ABPLI
ABQBU
ABQSL
ABSXP
ABTEG
ABTKH
ABTMW
ABULA
ABUWG
ABWNU
ABXPI
ACAOD
ACBXY
ACDTI
ACGFS
ACHSB
ACHXU
ACIWK
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACPIV
ACPRK
ACUDM
ACZOJ
ADBBV
ADHHG
ADHIR
ADIMF
ADINQ
ADJJI
ADKNI
ADKPE
ADRFC
ADTPH
ADURQ
ADYFF
ADZKW
AEBTG
AEFIE
AEFQL
AEGAL
AEGNC
AEJHL
AEJRE
AEKMD
AEMSY
AENEX
AEOHA
AEPYU
AESKC
AETLH
AEVLU
AEXYK
AFBBN
AFEXP
AFKRA
AFLOW
AFQWF
AFRAH
AFWTZ
AFZKB
AGAYW
AGDGC
AGGDS
AGJBK
AGMZJ
AGQEE
AGQMX
AGRTI
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHIZS
AHKAY
AHMBA
AHSBF
AHYZX
AIAKS
AIGIU
AIIXL
AILAN
AITGF
AJBLW
AJRNO
AJZVZ
AKMHD
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMXSW
AMYLF
AMYQR
AOCGG
ARMRJ
ASPBG
AVWKF
AXYYD
AZFZN
AZQEC
B-.
BA0
BBWZM
BDATZ
BENPR
BGNMA
BPHCQ
BSONS
BVXVI
CAG
CCPQU
COF
CS3
CSCUP
DDRTE
DL5
DNIVK
DPUIP
DU5
DWQXO
EBD
EBLON
EBS
EIOEI
EJD
EMB
EMOBN
EN4
ESBYG
F5P
FEDTE
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
FYUFA
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNUQQ
GNWQR
GQ6
GQ7
GQ8
GRRUI
GUQSH
GXS
H13
HF~
HG5
HG6
HMCUK
HMJXF
HQYDN
HRMNR
HVGLF
HZ~
I09
IHE
IJ-
IKXTQ
IMOTQ
IWAJR
IXC
IXD
IXE
IZIGR
IZQ
I~X
I~Z
J-C
J0Z
JBSCW
JCJTX
JZLTJ
KDC
KOV
KOW
KPH
LAS
LLZTM
M1P
M2O
M4Y
MA-
N2Q
N9A
NB0
NDZJH
NPVJJ
NQJWS
NU0
O9-
O93
O9G
O9I
O9J
OAM
P19
P9S
PF0
PQQKQ
PROAC
PSQYO
PT4
PT5
Q2X
QOK
QOR
QOS
R4E
R89
R9I
RHV
RIG
RNI
ROL
RPX
RRX
RSV
RZK
S16
S1Z
S26
S27
S28
S37
S3B
SAP
SCLPG
SDE
SDH
SDM
SHX
SISQX
SJYHP
SMD
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SV3
SZ9
SZN
T13
T16
TSG
TSK
TSV
TT1
TUC
U2A
U9L
UG4
UKHRP
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W23
W48
WJK
WK8
YLTOR
Z45
Z7U
Z82
Z87
Z8O
Z8V
Z91
ZGI
ZMTXR
ZOVNA
ZXP
~A9
~EX
AAPKM
AAYXX
ABBRH
ABDBE
ABFSG
ABRTQ
ACSTC
ADHKG
AEZWR
AFDZB
AFHIU
AFOHR
AGQPQ
AHPBZ
AHWEU
AIXLP
ATHPR
AYFIA
CITATION
NAPCQ
PHGZM
PHGZT
PJZUB
PPXIY
PUEGO
CGR
CUY
CVF
ECM
EIF
NPM
7QO
7RV
7XB
8FD
8FK
FR3
K9.
MBDVC
P64
PKEHL
PQEST
PQUKI
PRINS
Q9U
7X8
ID FETCH-LOGICAL-c396t-d8961d17da081dcd34f09a3d0bce1c2e6bd8d42126af4d7496390b17eb2e84423
IEDL.DBID AGYKE
ISSN 0910-8327
1615-2573
IngestDate Sun Sep 28 02:42:12 EDT 2025
Wed Sep 17 23:56:07 EDT 2025
Thu Apr 03 06:57:04 EDT 2025
Thu Apr 24 23:10:22 EDT 2025
Wed Oct 01 01:31:21 EDT 2025
Fri Feb 21 02:27:25 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords Percutaneous coronary intervention
Statin
Angina pectoris
Atherosclerosis
Language English
License http://www.springer.com/tdm
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c396t-d8961d17da081dcd34f09a3d0bce1c2e6bd8d42126af4d7496390b17eb2e84423
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 14
content type line 23
ObjectType-Undefined-3
PMID 21643812
PQID 1462391406
PQPubID 36867
PageCount 7
ParticipantIDs proquest_miscellaneous_1024936708
proquest_journals_1462391406
pubmed_primary_21643812
crossref_primary_10_1007_s00380_011_0156_y
crossref_citationtrail_10_1007_s00380_011_0156_y
springer_journals_10_1007_s00380_011_0156_y
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20120700
2012-7-00
2012-Jul
20120701
PublicationDateYYYYMMDD 2012-07-01
PublicationDate_xml – month: 7
  year: 2012
  text: 20120700
PublicationDecade 2010
PublicationPlace Japan
PublicationPlace_xml – name: Japan
– name: Tokyo
PublicationTitle Heart and vessels
PublicationTitleAbbrev Heart Vessels
PublicationTitleAlternate Heart Vessels
PublicationYear 2012
Publisher Springer Japan
Springer Nature B.V
Publisher_xml – name: Springer Japan
– name: Springer Nature B.V
References Shamsuzzaman, Winnicki, Wolk, Svatikova, Phillips, Davison, Berger, Somers (CR27) 2004; 109
Cao (CR22) 2007; 117
Oka, Ikeda, Koga, Miyahara, Kohno (CR24) 2008; 23
von Eynatten, Schneider, Hadziselimovic, Hamman, Bierhaus, Nawroth, Dugi (CR26) 2005; 28
Sierra-Honigmann, Nath, Murakami, Garcia-Cardena, Papapetropoulos, Sessa, Madge, Schechner, Schwabb, Polverini, Flores-Riveros (CR3) 1998; 281
Bouloumie, Marumo, Lafontan, Busse (CR19) 1999; 13
Wallerstedt, Eriksson, Nikiason, Ohisson, Hedner (CR14) 2004; 13
Cannon, Braunwald, McCabe, Rader, Rouleau, Belder, Joyal, Hill, Pfeffer, Skene (CR9) 2004; 350
Davignon (CR23) 2004; 109
Strandberg, Vanhangen, Tikkanen (CR29) 1999; 353
Satani, Konya, Hamaguchi, Umehara, Katsuno, Ishikawa, Kohri, Suehiro, Kakishita, Namba (CR7) 2003; 23
Park, Kwon, Lim, Hong, Lee, Park, Jang, Cho, Kim (CR17) 2001; 33
Djoba Siawaya, Roberts, Babb, Black, Golakai, Stanley, Bapela, Hoal, Parida, van Helden, Walzl (CR11) 2008; 3
La Cava, Matarese (CR4) 2004; 4
Lee, Lip, Blann (CR6) 2004; 110
Nissen (CR10) 2005; 96
Cao, Brakenhieim, Wahlestedt, Thyberg, Cao (CR18) 2001; 98
Nissen, Tuzcu, Schoenhagen, Brown, Ganz, Vogel, Crowe, Howard, Cooper, Brodie, Grines, DeMaria (CR8) 2004; 291
Beltowski (CR2) 2006; 189
Wallace, McMahon, Packard, Kelly, Shepherd, Gaw, Sattar (CR5) 2001; 104
Singhal, Farooqi, Cole, O’Rahilly, Fewtrell, Kattenhorn, Lucas, Deanfield (CR15) 2002; 106
Peelman, Waelput, Iserentant, Lavens, Eyckerman, Zabeau, Tavernier (CR16) 2004; 43
Zhao, Wu (CR25) 2005; 360
Mavri, Poredoš, Suran, Gaborit, Juhan-Vague, Poredoš (CR20) 2011; 26
Woods, Stock (CR1) 1996; 381
Chiba, Shinozaki, Nakazawa, Kawakami, Ai, Kaneko, Kitagawa, Kondo, Chait, Shimokado (CR21) 2008; 196
Soderberg, Ahren, Jansson, Johnson, Hallmans, Asplund, Olsson (CR13) 1999; 246
Söderberg, Colquhoun, Keech, Yallop, Barnes, Pollicino, Simes, Tonkin, Nestel, Study Investigators (CR28) 2008; 33
Friedewald, Levy, Fredrickson (CR12) 1972; 18
WT Friedewald (156_CR12) 1972; 18
HY Park (156_CR17) 2001; 33
CP Cannon (156_CR9) 2004; 350
SM Wallerstedt (156_CR14) 2004; 13
T Chiba (156_CR21) 2008; 196
AS Shamsuzzaman (156_CR27) 2004; 109
Y Cao (156_CR22) 2007; 117
F Peelman (156_CR16) 2004; 43
TE Strandberg (156_CR29) 1999; 353
S Söderberg (156_CR28) 2008; 33
AJ Woods (156_CR1) 1996; 381
K Satani (156_CR7) 2003; 23
A Bouloumie (156_CR19) 1999; 13
SE Nissen (156_CR8) 2004; 291
A Singhal (156_CR15) 2002; 106
SE Nissen (156_CR10) 2005; 96
J Beltowski (156_CR2) 2006; 189
JF Djoba Siawaya (156_CR11) 2008; 3
KW Lee (156_CR6) 2004; 110
S Soderberg (156_CR13) 1999; 246
MR Sierra-Honigmann (156_CR3) 1998; 281
M Eynatten von (156_CR26) 2005; 28
SP Zhao (156_CR25) 2005; 360
R Cao (156_CR18) 2001; 98
A Mavri (156_CR20) 2011; 26
H Oka (156_CR24) 2008; 23
A La Cava (156_CR4) 2004; 4
AM Wallace (156_CR5) 2001; 104
156_CR23
10023901 - Lancet. 1999 Jan 9;353(9147):118-9
9733517 - Science. 1998 Sep 11;281(5383):1683-6
16759302 - Diabet Med. 2006 Jun;23 (6):617-22
15581339 - Blood Press. 2004;13(4):243-6
20922535 - Heart Vessels. 2011 Jan;26(1):31-8
15234549 - Prog Lipid Res. 2004 Jul;43(4):283-301
15122202 - Nat Rev Immunol. 2004 May;4(5):371-9
16014304 - Clin Chim Acta. 2005 Oct;360(1-2):133-40
17362969 - Atherosclerosis. 2008 Jan;196(1):68-75
10385613 - FASEB J. 1999 Jul;13(10):1231-8
11460888 - Exp Mol Med. 2001 Jun 30;33(2):95-102
11344271 - Proc Natl Acad Sci U S A. 2001 May 22;98(11):6390-5
15007110 - N Engl J Med. 2004 Apr 8;350(15):1495-504
10583712 - J Intern Med. 1999 Oct;246(4):409-18
15117839 - Circulation. 2004 May 11;109(18):2181-5
15198965 - Circulation. 2004 Jun 15;109(23 Suppl 1):III39-43
16580676 - Atherosclerosis. 2006 Nov;189(1):47-60
4337382 - Clin Chem. 1972 Jun;18(6):499-502
14996776 - JAMA. 2004 Mar 3;291(9):1071-80
15735224 - Diabetes Care. 2005 Mar;28(3):754-5
15302795 - Circulation. 2004 Oct 19;110(16):2355-60
18649055 - Heart Vessels. 2008 Jul;23(4):249-56
12370213 - Circulation. 2002 Oct 8;106(15):1919-24
16126025 - Am J Cardiol. 2005 Sep 5;96(5A):61F-68F
17786229 - J Clin Invest. 2007 Sep;117(9):2362-8
19050671 - Int J Obes (Lond). 2009 Jan;33(1):123-30
18596971 - PLoS One. 2008 Jul 02;3(7):e2535
11748099 - Circulation. 2001 Dec 18;104(25):3052-6
8657278 - Nature. 1996 Jun 27;381(6585):745
References_xml – volume: 117
  start-page: 2362
  year: 2007
  end-page: 2368
  ident: CR22
  article-title: Angiogenesis modulates adipogenesis and obesity
  publication-title: J Clin Invest
  doi: 10.1172/JCI32239
– volume: 33
  start-page: 123
  year: 2008
  end-page: 130
  ident: CR28
  article-title: Leptin, but not adiponectin, is a predictor of recurrent cardiovascular events in men: results from the LIPID study
  publication-title: Int J Obes (Lond)
  doi: 10.1038/ijo.2008.224
– volume: 109
  start-page: III39
  issue: Suppl 1
  year: 2004
  end-page: 43
  ident: CR23
  article-title: Beneficial cardiovascular pleiotropic effects of statins
  publication-title: Circulation
– volume: 4
  start-page: 371
  year: 2004
  end-page: 379
  ident: CR4
  article-title: The weight of leptin in immunity
  publication-title: Nat Rev Immunol
  doi: 10.1038/nri1350
– volume: 110
  start-page: 2355
  year: 2004
  end-page: 2360
  ident: CR6
  article-title: Plasma angiopoietin-1, angiopoietin-2, angiopoietin receptor tie-2, and vascular endothelial growth factor levels in acute coronary syndromes
  publication-title: Circulation
  doi: 10.1161/01.CIR.0000138112.90641.7F
– volume: 33
  start-page: 95
  year: 2001
  end-page: 102
  ident: CR17
  article-title: Potential role of leptin in angiogenesis: leptin induces endothelial cell proliferation and expression of matrix metalloproteinases in vivo and in vitro
  publication-title: Exp Mol Med
– volume: 43
  start-page: 283
  year: 2004
  end-page: 301
  ident: CR16
  article-title: Leptin: linking adipocyte metabolism with cardiovascular and autoimmune diseases
  publication-title: Prog Lipid Res
  doi: 10.1016/j.plipres.2004.03.001
– volume: 360
  start-page: 133
  year: 2005
  end-page: 140
  ident: CR25
  article-title: Atorvastatin reduces serum leptin concentration in hypercholesterolemic rabbits
  publication-title: Clin Chim Acta
  doi: 10.1016/j.cccn.2005.04.021
– volume: 381
  start-page: 745
  year: 1996
  ident: CR1
  article-title: Leptin activation in hypothalamus
  publication-title: Nature
  doi: 10.1038/381745a0
– volume: 18
  start-page: 499
  year: 1972
  end-page: 502
  ident: CR12
  article-title: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge
  publication-title: Clin Chem
– volume: 3
  start-page: e2535
  year: 2008
  ident: CR11
  article-title: An evaluation of commercial fluorescent bead-based luminex cytokine assays
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0002535
– volume: 281
  start-page: 1683
  year: 1998
  end-page: 1686
  ident: CR3
  article-title: Biological action of leptin as an angiogenic factor
  publication-title: Science
  doi: 10.1126/science.281.5383.1683
– volume: 350
  start-page: 1495
  year: 2004
  end-page: 1504
  ident: CR9
  article-title: Intensive versus moderate lipid lowering with statins after acute coronary syndromes
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa040583
– volume: 13
  start-page: 1231
  year: 1999
  end-page: 1238
  ident: CR19
  article-title: Leptin induces oxidative stress in human endothelial cells
  publication-title: FASEB J
– volume: 23
  start-page: 617
  year: 2003
  end-page: 622
  ident: CR7
  article-title: Clinical significance of circulating hepatocyte growth factor, a new risk marker of carotid atherosclerosis in patients with type 2 diabetes
  publication-title: Diabet Med
  doi: 10.1111/j.1464-5491.2006.01849.x
– volume: 26
  start-page: 31
  year: 2011
  end-page: 38
  ident: CR20
  article-title: Effect of diet-induced weight loss on endothelial dysfunction: early improvement after the first week of dieting
  publication-title: Heart Vessels
  doi: 10.1007/s00380-010-0016-1
– volume: 246
  start-page: 409
  year: 1999
  end-page: 418
  ident: CR13
  article-title: Leptin is associated with increased risk of myocardial infarction
  publication-title: J Intern Med
  doi: 10.1046/j.1365-2796.1999.00571.x
– volume: 353
  start-page: 118
  year: 1999
  end-page: 119
  ident: CR29
  article-title: Effect of statins on C-reactive protein in patients with coronary artery disease
  publication-title: Lancet
  doi: 10.1016/S0140-6736(05)76154-7
– volume: 28
  start-page: 754
  year: 2005
  end-page: 755
  ident: CR26
  article-title: Adipocytokines as a novel target for the anti-inflammatory effect of atorvastatin in patients with type 2 diabetes
  publication-title: Diabetes Care
  doi: 10.2337/diacare.28.3.754
– volume: 13
  start-page: 243
  year: 2004
  end-page: 246
  ident: CR14
  article-title: Serum leptin and myocardial infarction in hypertension
  publication-title: Blood Press
  doi: 10.1080/08037050410021405
– volume: 23
  start-page: 249
  year: 2008
  end-page: 256
  ident: CR24
  article-title: Atorvastatin induces associated reductions in platelet P-selectin, oxidized low-density lipoprotein, and interleukin-6 in patients with coronary artery diseases
  publication-title: Heart Vessel
  doi: 10.1007/s00380-008-1038-9
– volume: 104
  start-page: 3052
  year: 2001
  end-page: 3056
  ident: CR5
  article-title: Plasma leptin and the risk of cardiovascular disease in the West of Scotland Coronary Prevention Study (WOSCOPS)
  publication-title: Circulation
  doi: 10.1161/hc5001.101061
– volume: 106
  start-page: 1919
  year: 2002
  end-page: 1924
  ident: CR15
  article-title: Influence of leptin on arterial distensibility: a novel link between obesity and cardiovascular disease?
  publication-title: Circulation
  doi: 10.1161/01.CIR.0000033219.24717.52
– volume: 98
  start-page: 6390
  year: 2001
  end-page: 6395
  ident: CR18
  article-title: Leptin induces vascular permeability and synergistically stimulates angiogenesis with FGF-2 and VEGF
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.101564798
– volume: 189
  start-page: 47
  year: 2006
  end-page: 60
  ident: CR2
  article-title: Leptin and atherosclerosis
  publication-title: Atherosclerosis
  doi: 10.1016/j.atherosclerosis.2006.03.003
– volume: 291
  start-page: 1071
  year: 2004
  end-page: 1080
  ident: CR8
  article-title: Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial
  publication-title: JAMA
  doi: 10.1001/jama.291.9.1071
– volume: 109
  start-page: 2181
  year: 2004
  end-page: 2185
  ident: CR27
  article-title: Independent association between plasma leptin and C-reactive protein in healthy humans
  publication-title: Circulation
  doi: 10.1161/01.CIR.0000127960.28627.75
– volume: 96
  start-page: 61F
  year: 2005
  end-page: 68F
  ident: CR10
  article-title: Effect of intensive lipid lowering on progression of coronary atherosclerosis: evidence for an early benefit from the reversal of atherosclerosis with aggressive lipid lowering (REVERSAL) trial
  publication-title: Am J Cardiol
  doi: 10.1016/j.amjcard.2005.07.013
– volume: 196
  start-page: 68
  year: 2008
  end-page: 75
  ident: CR21
  article-title: Leptin deficiency suppresses progression of atherosclerosis in apoE-deficient mice
  publication-title: Atherosclerosis
  doi: 10.1016/j.atherosclerosis.2007.01.040
– volume: 110
  start-page: 2355
  year: 2004
  ident: 156_CR6
  publication-title: Circulation
  doi: 10.1161/01.CIR.0000138112.90641.7F
– volume: 23
  start-page: 249
  year: 2008
  ident: 156_CR24
  publication-title: Heart Vessel
  doi: 10.1007/s00380-008-1038-9
– volume: 189
  start-page: 47
  year: 2006
  ident: 156_CR2
  publication-title: Atherosclerosis
  doi: 10.1016/j.atherosclerosis.2006.03.003
– volume: 26
  start-page: 31
  year: 2011
  ident: 156_CR20
  publication-title: Heart Vessels
  doi: 10.1007/s00380-010-0016-1
– volume: 196
  start-page: 68
  year: 2008
  ident: 156_CR21
  publication-title: Atherosclerosis
  doi: 10.1016/j.atherosclerosis.2007.01.040
– volume: 33
  start-page: 95
  year: 2001
  ident: 156_CR17
  publication-title: Exp Mol Med
  doi: 10.1038/emm.2001.17
– volume: 3
  start-page: e2535
  year: 2008
  ident: 156_CR11
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0002535
– volume: 18
  start-page: 499
  year: 1972
  ident: 156_CR12
  publication-title: Clin Chem
  doi: 10.1093/clinchem/18.6.499
– volume: 98
  start-page: 6390
  year: 2001
  ident: 156_CR18
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.101564798
– volume: 246
  start-page: 409
  year: 1999
  ident: 156_CR13
  publication-title: J Intern Med
  doi: 10.1046/j.1365-2796.1999.00571.x
– volume: 4
  start-page: 371
  year: 2004
  ident: 156_CR4
  publication-title: Nat Rev Immunol
  doi: 10.1038/nri1350
– volume: 106
  start-page: 1919
  year: 2002
  ident: 156_CR15
  publication-title: Circulation
  doi: 10.1161/01.CIR.0000033219.24717.52
– ident: 156_CR23
  doi: 10.1161/01.CIR.0000131517.20177.5a
– volume: 360
  start-page: 133
  year: 2005
  ident: 156_CR25
  publication-title: Clin Chim Acta
  doi: 10.1016/j.cccn.2005.04.021
– volume: 281
  start-page: 1683
  year: 1998
  ident: 156_CR3
  publication-title: Science
  doi: 10.1126/science.281.5383.1683
– volume: 104
  start-page: 3052
  year: 2001
  ident: 156_CR5
  publication-title: Circulation
  doi: 10.1161/hc5001.101061
– volume: 13
  start-page: 1231
  year: 1999
  ident: 156_CR19
  publication-title: FASEB J
  doi: 10.1096/fasebj.13.10.1231
– volume: 33
  start-page: 123
  year: 2008
  ident: 156_CR28
  publication-title: Int J Obes (Lond)
  doi: 10.1038/ijo.2008.224
– volume: 353
  start-page: 118
  year: 1999
  ident: 156_CR29
  publication-title: Lancet
  doi: 10.1016/S0140-6736(05)76154-7
– volume: 350
  start-page: 1495
  year: 2004
  ident: 156_CR9
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa040583
– volume: 28
  start-page: 754
  year: 2005
  ident: 156_CR26
  publication-title: Diabetes Care
  doi: 10.2337/diacare.28.3.754
– volume: 23
  start-page: 617
  year: 2003
  ident: 156_CR7
  publication-title: Diabet Med
  doi: 10.1111/j.1464-5491.2006.01849.x
– volume: 96
  start-page: 61F
  year: 2005
  ident: 156_CR10
  publication-title: Am J Cardiol
  doi: 10.1016/j.amjcard.2005.07.013
– volume: 117
  start-page: 2362
  year: 2007
  ident: 156_CR22
  publication-title: J Clin Invest
  doi: 10.1172/JCI32239
– volume: 291
  start-page: 1071
  year: 2004
  ident: 156_CR8
  publication-title: JAMA
  doi: 10.1001/jama.291.9.1071
– volume: 13
  start-page: 243
  year: 2004
  ident: 156_CR14
  publication-title: Blood Press
  doi: 10.1080/08037050410021405
– volume: 381
  start-page: 745
  year: 1996
  ident: 156_CR1
  publication-title: Nature
  doi: 10.1038/381745a0
– volume: 109
  start-page: 2181
  year: 2004
  ident: 156_CR27
  publication-title: Circulation
  doi: 10.1161/01.CIR.0000127960.28627.75
– volume: 43
  start-page: 283
  year: 2004
  ident: 156_CR16
  publication-title: Prog Lipid Res
  doi: 10.1016/j.plipres.2004.03.001
– reference: 12370213 - Circulation. 2002 Oct 8;106(15):1919-24
– reference: 15581339 - Blood Press. 2004;13(4):243-6
– reference: 14996776 - JAMA. 2004 Mar 3;291(9):1071-80
– reference: 9733517 - Science. 1998 Sep 11;281(5383):1683-6
– reference: 15302795 - Circulation. 2004 Oct 19;110(16):2355-60
– reference: 10023901 - Lancet. 1999 Jan 9;353(9147):118-9
– reference: 18596971 - PLoS One. 2008 Jul 02;3(7):e2535
– reference: 15007110 - N Engl J Med. 2004 Apr 8;350(15):1495-504
– reference: 15198965 - Circulation. 2004 Jun 15;109(23 Suppl 1):III39-43
– reference: 17362969 - Atherosclerosis. 2008 Jan;196(1):68-75
– reference: 11344271 - Proc Natl Acad Sci U S A. 2001 May 22;98(11):6390-5
– reference: 15735224 - Diabetes Care. 2005 Mar;28(3):754-5
– reference: 20922535 - Heart Vessels. 2011 Jan;26(1):31-8
– reference: 15234549 - Prog Lipid Res. 2004 Jul;43(4):283-301
– reference: 4337382 - Clin Chem. 1972 Jun;18(6):499-502
– reference: 10385613 - FASEB J. 1999 Jul;13(10):1231-8
– reference: 10583712 - J Intern Med. 1999 Oct;246(4):409-18
– reference: 11460888 - Exp Mol Med. 2001 Jun 30;33(2):95-102
– reference: 8657278 - Nature. 1996 Jun 27;381(6585):745
– reference: 18649055 - Heart Vessels. 2008 Jul;23(4):249-56
– reference: 16126025 - Am J Cardiol. 2005 Sep 5;96(5A):61F-68F
– reference: 16759302 - Diabet Med. 2006 Jun;23 (6):617-22
– reference: 17786229 - J Clin Invest. 2007 Sep;117(9):2362-8
– reference: 16014304 - Clin Chim Acta. 2005 Oct;360(1-2):133-40
– reference: 19050671 - Int J Obes (Lond). 2009 Jan;33(1):123-30
– reference: 11748099 - Circulation. 2001 Dec 18;104(25):3052-6
– reference: 16580676 - Atherosclerosis. 2006 Nov;189(1):47-60
– reference: 15117839 - Circulation. 2004 May 11;109(18):2181-5
– reference: 15122202 - Nat Rev Immunol. 2004 May;4(5):371-9
SSID ssj0015919
Score 2.0841513
Snippet Leptin has been reported to exert an atherosclerotic effect by regulating expression of angiogenic factors that have been implicated in the pathogenesis of...
SourceID proquest
pubmed
crossref
springer
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 337
SubjectTerms Aged
Analysis of Variance
Angina pectoris
Angiogenesis
Angiogenic Proteins - blood
Angiopoietin-2 - blood
Atherosclerosis
Atorvastatin Calcium
Biomarkers - blood
Biomedical Engineering and Bioengineering
Cardiac Surgery
Cardiology
Coronary Artery Disease - blood
Coronary Artery Disease - drug therapy
Down-Regulation
Female
Hepatocyte Growth Factor - blood
Heptanoic Acids - therapeutic use
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use
Japan
Leptin - blood
Lipids - blood
Male
Medicine
Medicine & Public Health
Middle Aged
Original Article
Pravastatin - therapeutic use
Prospective Studies
Pyrroles - therapeutic use
Single-Blind Method
Statins
Time Factors
Treatment Outcome
Vascular endothelial growth factor
Vascular Endothelial Growth Factor A - blood
Vascular Surgery
SummonAdditionalLinks – databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1ba9VAEB60gvgi2nqJVhlBFLSLuXWTfZIiliIoPlg4b2Gzu9EDp8nx5Bwh_jv_mTObTVSKfQiEXDYJM7vzzcyXGYDnttA6bQojcmmUyJ1qhHLSCKVZXYwhE-EJsp_k2Xn-YXG8CAG3PtAqpzXRL9S2Mxwjf0MzOs0UuQPy7fq74K5RnF0NLTSuw42EoAprdbGYHS6y1MlYa4_WGtLcYspqxr6IaFYyJYud6WMphn_t0iWweSlR6u3P6R24HYAjnoySvgvXXLsPByctOc0XA75AT-X0MfJ9uPkxZMwP4NfnTTf9TXmEZJhsd7H86ewRcpBg5URNONOimdsRYtdgIHnwrkT68O23_iXOlHTk2C2ys_5D8_9IyxaZ27Hrcb3R8yEaacWMmRbpmbR9XXakq0uDocMP0plQ1LUfRzRcTEFvBvQ00wFD7ugenJ--__LuTIS2DcJkSm6FLZVMbFJYTXDDGpvlTax0ZuPauMSkTta2tJyIlrrJbZHTEqDiOinIx3dlTvDuPuy1XeseAuoyZ8RRl4zrEqNqnbkyc4WpM0PAzUYQT0KrTKhpzq01VtVcjdnLuSI5Vyznaojg1XzLeizocdXFh5MmVGFu99UfTYzg2XyaZiWnWnTruh1dw5UYuTZeGcGDUYPmp6XkoRJOSiN4PanUX4P_71UeXf0qj-EWQblAJD6Eve1m554QXNrWT_2c-A1S0RTz
  priority: 102
  providerName: ProQuest
Title Prospective, randomized, single-blind comparison of effects of 6 months' treatment with atorvastatin versus pravastatin on leptin and angiogenic factors in patients with coronary artery disease
URI https://link.springer.com/article/10.1007/s00380-011-0156-y
https://www.ncbi.nlm.nih.gov/pubmed/21643812
https://www.proquest.com/docview/1462391406
https://www.proquest.com/docview/1024936708
Volume 27
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVLSH
  databaseName: SpringerLink Journals
  customDbUrl:
  mediaType: online
  eissn: 1615-2573
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0015919
  issn: 0910-8327
  databaseCode: AFBBN
  dateStart: 19970101
  isFulltext: true
  providerName: Library Specific Holdings
– providerCode: PRVPQU
  databaseName: Health & Medical Collection
  customDbUrl:
  eissn: 1615-2573
  dateEnd: 20181231
  omitProxy: true
  ssIdentifier: ssj0015919
  issn: 0910-8327
  databaseCode: 7X7
  dateStart: 20000101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl: http://www.proquest.com/pqcentral?accountid=15518
  eissn: 1615-2573
  dateEnd: 20181231
  omitProxy: true
  ssIdentifier: ssj0015919
  issn: 0910-8327
  databaseCode: BENPR
  dateStart: 20000101
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVAVX
  databaseName: SpringerLINK - Czech Republic Consortium
  customDbUrl:
  eissn: 1615-2573
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0015919
  issn: 0910-8327
  databaseCode: AGYKE
  dateStart: 19970101
  isFulltext: true
  titleUrlDefault: http://link.springer.com
  providerName: Springer Nature
– providerCode: PRVAVX
  databaseName: SpringerLink Journals (ICM)
  customDbUrl:
  eissn: 1615-2573
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0015919
  issn: 0910-8327
  databaseCode: U2A
  dateStart: 19970101
  isFulltext: true
  titleUrlDefault: http://www.springerlink.com/journals/
  providerName: Springer Nature
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1ba9RAFD7YFsQXL62XaC0jiII2ZXPZSeZxla1FsRTpwvoU5hZd3CZlkxXSX-Nv6S_znGQS1KrQh5CQTCYT5szMd-Z88w3Ac5NIGeaJ9mOuhR9bkfvCcu0LSeaiNQ4RLUH2mB_N4vfz8dyt4656tnsfkmx76mGxGwWxiERF7u-Y-80GbI3RP8HWuDV59_nDdAgejEXQSexhF4MGm_TBzL9l8vtwdAVjXomPtsPO4R047QvcsU2-HaxrdaAv_tByvOYf3YXbDoaySWc39-CGLbZhZ1KgC37WsBesJYa2M-7bcPOji7_vwOXJquzXZu4zHOZMeba4sGaf0ZTD0voKy2GYHjY3ZGXOHGWELvnlDzT7-mv1kg0Md0ZTwYx8_--SljctCkZUkXXFzldyuIVZLYmAUzD8KB5fFiWa_kIzt2EQwydOI7bqctSkzSBXDWtZqw1zoaj7MDucnr498t0uEL6OBK99kwoemCAxEtGL0SaK85GQkRkpbQMdWq5MaiiuzWUemyTGHkWMVJBYFdo0RrT4ADaLsrCPgMk0JgCjUoKJgRZKRjaNbKJVpBEHGg9GvTFk2kmk004dy2wQd26rLMMqy6jKssaDV8Mr550-yP8S7_YWlrmuoiLfK4wE-rncg2fDY2zkFLmRhS3XmIaEHUlqL_XgYWeZw9dCdHgRdoUevO6t7JfM_1WUx9dK_QRuIVB0NOVd2KxXa_sUwVit9mAjmSd7rgni-c30-OQT3p2Fk5_bxTOa
linkProvider Springer Nature
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1ba9RAFB5KBfVFtPWSWvUIXkA7mMt0knkQKWrZ2gs-tLBv6WRmYhe2ybrZVeKP8j_4zzwnN5Vi3_qwEDbJJOTcvnOZcxh7ZmOtwzw2XEijuHAq58pJw5UmdjEGTURTIHskRyfi03h7vMJ-9nthqKyy14mNoraloRj5G5ToMFLoDsh3s6-cpkZRdrUfodGyxb6rv6PLVr3d-4D0fR6Gux-P3494N1WAm0jJBbeJkoENYqvRGlpjI5H7SkfWz4wLTOhkZhNLeVKpc2FjgRyq_CyI0QV1iRDU6ABV_jVBKUaUn3g8OHiIDIK2tx_qNpSUuM-i-k3T0iihEjBy3rclr_-1gxfA7YXEbGPvdm-zWx1QhZ2Ws-6wFVessfWdAp308xpeQFM62sTk19j1wy5Dv85-fZ6X_e7NLUBDaMvzyQ9nt4CCElPHM8S1Fsww_hDKHLqiEjqUgB96cVa9hKEEHihWDBQc-KZp_9OkAKolWVYwm-vhL1xpShU6BeAz8fdlUqJsTAx0E4UAz3RNZKt2RUPNG_S8hqastYYuV3WXnVwJQe-x1aIs3AMGOhGEcLKEcGRgVKYjl0QuNllkEChaj_k90VLT9VCnUR7TdOj-3NA5RTqnROe09tir4ZZZ20Dksos3e05IO11SpX8432NPh9OoBSi1owtXLvEa6vxIvfgSj91vOWh4WogeMeKy0GOve5b6a_H_vcrG5a_yhN0YHR8epAd7R_sP2U2EkV0R8yZbXcyX7hFCtUX2uJEPYKdXLZC_ATXtUew
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1ti9NAEB70hMMvone-RE8dQRT0wjUv3WQ_FrWcb8d9sHDfwmZ3cxZ6SWlSIf4af8v9MmeSTVBOBT8USrPdlM5s5pmdZ58BeG4SpcIi0X4stPRjKwtfWqF9qdhdtKYQ0RFkT8TxIv5wNj1zfU7rge0-lCT7Mw2s0lQ2R2tTHI0H37igxYQqToWnwm-vw42YQjVzuhbhbCwjTGXQi-3Rw4ZcNxnKmn-a4vfAdAVtXqmUdgFofhtuOeSIs97Ud-CaLfdgf1ZS1nzR4gvsuJzdJvke7H52JfN9uDzdVMNxykOkyGSqi-V3aw6RdwlW1s_pzzCox36EWBXoWB78Vlz-IE9tvtYvcSSlI-_eIqfr3xSfSFqWyOyObY3rjRo_oqlWzJkpkW5Kr_NlRd661Oh6_CBdcbKudT-jZjkFtWmxI5q26KpHd2Exf_flzbHvGjf4OpKi8U0qRWCCxCgCHEabKC4mUkVmkmsb6NCK3KSGS9FCFbFJYnoIyEkeJJTl2zQmgHcPdsqqtA8AVRoz5shTRnaBlrmKbBrZROeRJuhmPJgMVsu0UzXn5hqrbNRj7gydkaEzNnTWevBq_Mq6l_T41-CDwRUyt7prTpfCSFJqKjx4Nl6mdcnFFlXaaktjWIuR1fFSD-73LjTeLaQclZBS6MHrwad-mfxvP-Xhf41-Crunb-fZp_cnHx_BTYJ5jmR8ADvNZmsfE5Rq8ifdcvkJ5xwaZA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Prospective%2C+randomized%2C+single-blind+comparison+of+effects+of+6%C2%A0months%27+treatment+with+atorvastatin+versus+pravastatin+on+leptin+and+angiogenic+factors+in+patients+with+coronary+artery+disease&rft.jtitle=Heart+and+vessels&rft.au=Takahashi%2C+Yuji&rft.au=Satoh%2C+Mamoru&rft.au=Tabuchi%2C+Tsuyoshi&rft.au=Nakamura%2C+Motoyuki&rft.date=2012-07-01&rft.issn=0910-8327&rft.eissn=1615-2573&rft.volume=27&rft.issue=4&rft.spage=337&rft.epage=343&rft_id=info:doi/10.1007%2Fs00380-011-0156-y&rft.externalDBID=n%2Fa&rft.externalDocID=10_1007_s00380_011_0156_y
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0910-8327&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0910-8327&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0910-8327&client=summon